Letters sent to healthcare professionals in October 2015
In October 2015, letters were sent to healthcare professionals to provide safety information for the anticancer medicines crizotinib and vemurafenib
has been sent to inform about the
A risk of potentiation of radiation toxicity.
has been sent to inform about theArticle citation: Drug Safety Update Vol 9 issue 4, November 2015: 3.
Published 12 November 2015